marijuana stocks news

Final Approval Documents Have Been Sent To Licensing Office Of Colorado M.E.D. For Final Approval To Transfer Management Control Of Denver Testing Lab To Pazoo, Inc Licensee Harris Lee Colorado

Pazoo, Inc. (OTC Pinks: PZOO) (German WKN#: A1J3DK), is extremely pleased to announce that the Colorado MED has reached the final stages of the approval process for the transfer of the lab management from the owner Front Range Analytics, LLC to Pazoo licensee Harris Lee Colorado, LLC as of Friday, February 12, 2016, pending final approval of the Marijuana Enforcement Division. The application has been sent to the Licensing office of the MED for the final procedural step of final approval.  This change of management will result in several important fundamental developments.

First, Pazoo through its wholly owned subsidiary will immediately transition from a small based consulting fee to earning money off of every single test conducted, dramatically increasing revenue generated. Secondly, through all of the aggressive marketing efforts over the last few months, numerous growers, edible producers, CBD and THC oil companies and hemp producers have committed to test with the Harris Lee Colorado lab management team with this transfer.

As previously released (12/4/15), this Colorado lab was approved for residual solvents testing (RSA) back in December.  Being certified for the RSA will open up the market for potential clients, including extraction labs and manufacturers, and will allow the lab to regain former clients who left last year because this crucial certification was not in place. Additionally, the lab has gained several new clients over the months of December and January and is poised for explosive growth.

Pazoo CEO David Cunic stated, “With so many delays in 2015 we are ecstatic to be able to announce to the public that Harris Lee Colorado is about to take over the management of the Denver Colorado testing lab. This means that Pazoo’s revenues in Denver will be lock step with the number of tests to be administered and accordingly we expect to be reporting a big increase in revenue immediately upon final approval. Thank you for all your support and for sticking with us. Everything is finally coming together.”

About Pazoo, Inc.:

Pazoo, Inc. is a company focused on health, wellness and safety. Our focus is to provide best-in-class laboratory testing of cannabis and cannabinoids to protect consumers from impurities, contaminants and other irregularities. Through our wholly owned subsidiaries, Harris Lee and MA & Associates, Pazoo provides industry leading laboratory testing of cannabis. Pazoo is licensed to test cannabis in Nevada, with a focus on expansion into other states. Additionally, Pazoo delivers a comprehensive array of health and wellness information on its websitewww.pazoo.com, and features industry experts from both the health and wellness arena and the pet industry. Lastly, our newly formed wholly owned subsidiary CK Distribution LLC, provides the marketing and sales agent for the distribution of non-controlled hemp products throughout the USA. Non-controlled hemp products are the items utilized by the industry that support grow facilities, infusion companies and dispensaries.

Safe Harbor Statement:

This update includes forward-looking statements. These forward-looking statements generally can be identified by phrases such as Pazoo, Inc. or its management “believes,” “expects,” “anticipates,” “foresees,” “forecasts,” “estimates” or other words or phrases of similar import. Similarly, statements herein that describe the Company’s business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statement.


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

GT Biopharma Inc. (GTBP) Announces Dr. Raymond W Urbanski Elevated to President and Chief Medical Officer of the Company

Gt Biopharma Announces Dr. Raymond W Urbanski Elevated to President and Chief…

$CBIS Files Preliminary Schedule 14C Filing

Cannabis Science Files Preliminary Schedule 14C Filing to Officially Issue Dividend Payouts…

Organigram Holdings Inc. (OGRMF) Receives Perimeter License Amendment for Phases 4A and 4B

Organigram Receives Perimeter License Amendment for Phases 4A and 4B as well…

$SING Signs Distribution Agreement to Partner With Glympse(R)

SinglePoint Signs Distribution Agreement to Partner With Glympse(R) on Marketing Real-Time Location…